Read our in-depth GHK-Cu research profile For In Vitro Research Use Only Not for Human or Veterinary Use Description Additional information For In Vitro Research Use Only Not for Human or Veterinary Use Molecular Weight 403.93 Daltons (complex) Genes Modulated 4,048 Connectivity Map Analysis Chemical & Physical Specifications About GHK-Cu (Copper Peptide Complex) GHK-Cu is a naturally occurring tripeptide-copper chelate first identified in human plasma by Pickart and Thaler in 1973
It is not FDA-approved for general therapeutic use in humans, and the World Anti-Doping Agency added it to its Prohibited List in 2022
Detailed Category Analysis# Receptor Targets# Retatrutide : Triple agonist: GIP, GLP-1, and glucagon receptors simultaneously Tirzepatide : Dual agonist: GIP and GLP-1 receptors Advantage : Retatrutide Weight Loss Efficacy# Retatrutide : Up to 28.7% body weight reduction at 68 weeks (Phase 3 TRIUMPH-4)
Over time, this helps: Repair damaged brain cells Strengthen neural pathways Improve mood, motivation, and thinking Think of BDNF like the Miracle-Gro for your brain
doi: 10.1093/nar/gkt441 48
There's not a lot of divergence or
